Mallinckrodt PLC

MNKKQ:OTCPK
RT Quote | Exchange | USD
Last | 01/21/21 EST
0.225quote price arrow down-0.0149 (-6.2109%)
Volume
1,260,864
52 week range
0.07 - 6.42

...

Loading . . .

KEY STATS

  • Open0.24
  • Day High0.24
  • Day Low0.22
  • Prev Close0.225
  • 52 Week High6.42
  • 52 Week High Date01/21/20
  • 52 Week Low0.07
  • 52 Week Low Date11/20/20
  • Market Cap19.03M
  • Shares Out84.60M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta3.85
  • 1 Year % Change-96.27

RATIOS/PROFITABILITY

  • EPS (TTM)-23.44
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)1,099.10M
  • ROE (MRQ)-93.10%
  • Revenue (MRQ)2,870.60M
  • Gross Margin (MRQ)44.14%
  • Net Margin (MRQ)-68.85%
  • Debt To Equity (MRQ)449.63%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Mallinckrodt PLC News

There is no recent news for this security.

Latest MNKKQ News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments...
Angus Russell
Non-Executive Chairman
Mark Trudeau
President
Bryan Reasons CPA
Chief Financial Officer
Mark Casey
Executive Vice President
Steven Romano M.D.
Executive Vice President
Address
College Business & Technology Park
Cruiserath, Blanchardstown
Dublin
Ireland